SKYE
Skye Bioscience, Inc. Common Stock
NASDAQ: SKYE · HEALTHCARE · BIOTECHNOLOGY
$0.88
-1.71% today
Updated 2026-04-30
Market cap
$22.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.30
Dividend yield
—
52W range
$1 – $6
Volume
0.6M
Skye Bioscience, Inc. Common Stock (SKYE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1928.00 | $-14495.00 | $-1.76M | $-3.73M | $-3.55M | $-3.30M | $-3.94M | $-6.03M | $-6.05M | $-6.47M | $-12.74M | $-13.95M | $-25.24M | $-43.06M |
| Capital expenditures | $0.00 | $49116.00 | $23262.00 | $1982.00 | $11117.00 | $19654.00 | $4385.00 | $7230.00 | $7230.00 | $90866.00 | $28060.00 | $12550.00 | $1.60M | $6312.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $10771.00 | $414343.00 | $706368.00 | $608676.00 | $674961.00 | $680455.00 | $302742.00 | $869206.00 | $629032.00 | $987510.00 | $8.32M | $7.77M |
| Free cash flow | $1928.00 | $-63611.00 | $-1.78M | $-3.73M | $-3.56M | $-3.32M | $-3.95M | $-6.04M | $-6.06M | $-6.57M | $-12.77M | $-13.96M | $-26.84M | $-43.07M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |